MedPath

Onderzoek naar ruggenmergstimulatie voor de behandeling van diabetische neuropathische pijn, een evaluatie studie

Recruiting
Conditions
diabetes mellitus, <br />diabetic neuropathic pain, <br />spinal cord stimulation,<br />diabetische neuropathische pijn,<br />ruggenmergstimulatie
Registration Number
NL-OMON29505
Lead Sponsor
Medisch Spectrum Twente,<br>Enschede, the Netherlands
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Peripheral neuropathic pain that exists for more than 6 months and is due to diabetes mellitus.

- Patient cannot be treated further otherwise according to patients’ medical specialist.

Exclusion Criteria

- Age < 18 years.

- Psychological problems that requires treatment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome measure is the change in neuropathic pain as measured by visual analogue scale (VAS) score after 6 months of SCS.
Secondary Outcome Measures
NameTimeMethod
- evaluation of patient preference of stimulation settings, <br /><br>- satisfaction with SCS treatment (PGIC),<br /><br>- evaluation of the efficacy of SCS treatment in patients with diabetic neuropathic pain as measured by mean and median percent change in pain intensity at all visits, <br>
© Copyright 2025. All Rights Reserved by MedPath